Analysis of blood coagulation in mice: Pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes

被引：25

作者：

Sommeijer D.W. ^{[1
]}

van Oerle R. ^{[3
]}

Reitsma P.H. ^{[1
]}

Timmerman J.J. ^{[1
]}

Meijers J.C.M. ^{[2
]}

Spronk H.M.H. ^{[3
]}

ten Cate H. ^{[3
]}

机构：

[1] Laboratory for Experimental Internal Medicine, Academic Medical Center of Amsterdam, Amsterdam

[2] Department of Vascular Medicine, Academic Medical Centre of Amsterdam, Amsterdam

[3] Laboratory for Clinical Thrombosis and Haemostasis, Department of Internal Medicine, University of Maastricht, Maastricht

来源：

Thrombosis Journal | / 3卷 / 1期

关键词：

Thrombin; Plasma Sample; Sodium Citrate; Activate Partial Thromboplastin Time; Coagulation Activation;

D O I：

10.1186/1477-9560-3-12

中图分类号：

学科分类号：

摘要：

Background: The use of mouse models for the study of thrombotic disorders has gained increasing importance. Methods for measurement of coagulation activation in mice are, however, scarce. The primary aim of this study was to develop a specific mouse thrombin-antithrombin (TAT) ELISA for measurement of coagulation activation and to compare it with two commercially available assays for human TAT complexes. In addition, we aimed to improve methods for mouse plasma anticoagulation and preparation. Methods and results: First, for the measurement of TAT-complexes in plasma a mouse specific TAT-ELISA was developed using rabbit polyclonal antibodies raised against mouse thrombin and rat antithrombin, respectively. This ELISA detected an increase in TAT levels in a mouse model of endotoxemia. Two commercial human TAT ELISAs appeared to be less specific for mouse thrombin-rat antithrombin complexes. Second, to prevent clotting of mouse blood sodium citrate was either mixed with blood during collection in a syringe or was injected intravenously immediately prior to blood collection. Intravenous sodium citrate completely inhibited blood coagulation resulting in plasma with consistently low TAT levels. Sodium citrate mixed with blood during collection resulted in increased TAT levels in 4 out of 16 plasma samples. Third, heparinase was added to plasma samples after in vivo injection of different heparin doses to test its neutralizing effect. Heparinase neutralized up to a 20 U of heparin/mouse and resulted in accurate APTT and factor VIII determinations. Conclusion: These procedures and reagents for plasma preparation and coagulation testing will improve studies on thrombotic disorders in mice. © 2005 Sommeijer et al; licensee BioMed Central Ltd.

引用

页数：10

共 11 条

[1]

Dorffler-Melly J., Schwarte L.A., Ince C., Levi M., Mouse models of focal arterial and venous thrombosis, Basic Res. Cardiol., 95, 6, pp. 503-509, (2000)

[2]

Kerlin B., Cooley B.C., Isermann B.H., Hernandez I., Sood R., Zogg M., Hendrickson S.B., Mosesson M.W., Lord S., Weiler H., Cause-effect relation between hyperfibrinogenemia and vascular disease, Blood, 103, 5, pp. 1728-1734, (2004)

[3]

Schafer K., Muller K., Hecke A., Mounier E., Goebel J., Loskutoff D.J., Konstantinides S., Enhanced thrombosis in atherosclerosisprone mice is associated with increased arterial expression of plasminogen activator inhibitor-1, Arterioscler. Thromb. Vasc. Biol., 23, 11, pp. 2097-2103, (2003)

[4]

Boisclair M.D., Lane D.A., Wilde J.T., Ireland H., Preston F.E., Ofosu F.A., A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: Thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen, Br. J. Haematol., 74, 4, pp. 471-479, (1990)

[5]

Pelzer H., Schwarz A., Heimburger N., Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay, Thromb. Haemost., 59, 1, pp. 101-106, (1988)

[6]

Manco-Johnson M.J., Nuss R., Jacobson L.J., Heparin neutralization is essential for accurate measurement of factor VIII activity and inhibitor assays in blood samples drawn from implanted venous access devices, J. Lab. Clin. Med., 136, 1, pp. 74-79, (2000)

[7]

Lane D.A., Caso R., Antithrombin structure, genomic organization, function and inherited deficiency, Baillieres Clin. Haematol., 2, 4, pp. 961-998, (1989)

[8]

Sugatani J., Igarashi T., Munakata M., Komiyama Y., Takahashi H., Komiyama N., Maeda T., Takeda T., Miwa M., Activation of coagulation in C57BL/6 mice given verotoxin 2 (VT2) and the effect of co-administration of LPS with VT2, Thromb. Res., 100, 1, pp. 61-72, (2000)

[9]

Mackman N., Sawdey M.S., Keeton M.R., Loskutoff D.J., Murine tissue factor gene expression in vivo. Tissue and cell specificity and regulation by lipopolysaccharide, Am. J. Pathol., 14, 1, pp. 76-84, (1993)

[10]

Yamamoto K., Loskutoff D.J., Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator, J. Clin. Invest., 97, 11, pp. 2440-2451, (1996)

← 1 2 →